Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OW 2026 14 - 17 November 2026

Real-World Clinical Outcomes with Semaglutide in a Population with Overweight or Class I Obesity

Authors :

Domenica Rubino1; Julia Wang2; Lauren Wilson2; Wojciech Michalak2; Susan Alford2; Francisco Lopez-Jimenez3

Affiliations
View Details Hide Details
Download the poster (.pdf)
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
RWE